American College of Cardiology (ACC)

The American College of Cardiology (ACC) is the primary U.S. medical society representing the interests of all cardiology subspecialities. The ACC is very active in setting guidelines for cardiac care, lobbying for supportive government policy and reimbursements, clinician education, managing several key cardiovascular registries and advocating for the transformation of cardiovascular care to improve heart health.

Success in treating congenital heart disease prompted need for new adult guidelines
The American College of Cardiology and American Heart Association have issued new guidelines for the management of congenital heart disease in adults. The document outlines how to manage these patients, the challenges they face and much more.
TAVR or SAVR? Market competition may be influencing these decisions
Hospitals located in more competitive markets may be more likely to perform TAVR instead of SAVR, according to a new analysis of more than 130,000 patients. Is this a reason for concern?
American College of Cardiology highlights the cardiovascular risks of various cancer treatments
The new guidance, published in JACC, focuses on three classes of commonly used anticancer therapies.
Women are more likely to have severe aortic stenosis missed on echocardiography results
Three out of four TTEs are being ordered by clinicians who are not cardiologists. Could this be having a negative impact on patient care?
Cardiologists join chorus of voices urging Trump administration to kill cybersecurity proposal
The proposal, first announced by the Biden administration, was developed to improve patient data security. Those opposed argue that it would significantly increase costs and create a logistical nightmare for hospitals and health systems throughout the country.

ACC.24: Self-expanding Evolut valves offer superior performance for TAVR patients with small annuli

The SMART trial included one-year data from TAVR patients randomized to receive either a self-expanding Evolut valve or a balloon-expandable Sapien 3 valve. All patients presented with symptomatic severe aortic stenosis and a small aortic annulus. A whopping 87% of participants were women.

semaglutide wegovy Novo Nordisk major adverse cardiovascular events

Weight loss drug semaglutide benefits obese patients presenting with HFpEF, type 2 diabetes

The new research, based on data from more than 600 patients, was presented at ACC.24 in Atlanta and published in the New England Journal of Medicine. Semaglutide is sold by Novo Nordisk under the brand name Wegovy.

ACC.24, the annual meeting of the American College of Cardiology (ACC), kicked off on Saturday, April 6, with a series of late-breaking clinical trials focused on testing the safety and effectiveness of new treatment strategies.

Day 1 at ACC.24: Late-breakers examine potential new heart attack, heart failure treatments

ACC.24 in Atlanta began Saturday, April 6, with a series of late-breaking clinical trials exploring brand new treatment strategies.

Transcatheter pulmonary valve replacement (TPVR) with Medtronic’s self-expanding Harmony valve is both safe and effective after more than a year, according to new real-world data published in the Journal of the American College of Cardiology.[1]

TPVR with self-expanding Harmony valve associated with ‘excellent’ real-world outcomes

Transcatheter pulmonary valve replacement is still linked to certain risks, researchers noted, but new data confirm it is a safe, effective treatment option for patients with severe PR.

Osso VR, a San Francisco-based virtual reality (VR) company, has developed a new VR training simulation focused on left atrial appendage occlusion (LAAO) procedures. The simulation is designed to offer clinicians a new way to practice LAAO procedures in a “repeatable, risk-free virtual environment.”

Cardiologist-approved VR for interventional procedures headed to ACC.24

San Francisco-based Osso VR and the American College of Cardiology have collaborated on advanced LAAO simulations. The two groups first started working together back in 2022.

GE Healthcare has announced the upcoming launch of new artificial intelligence (AI) software compatible with the company’s Vscan Air SL handheld ultrasound system.

GE Healthcare launching new AI software for handheld ultrasound system

The company's new AI offering, a product of its 2023 acquisition of Caption Health, will make its debut at ACC.24 in Atlanta.

cardiologist patient heart compensation starting salary 2022 interventional cardiologist

Cardiology groups want to ‘transform the future of cardiovascular medicine’ with new medical board

Leaders from the American Heart Association, American College of Cardiology, Heart Failure Society of America, Heart Rhythm Society and Society for Cardiovascular Angiography & Interventions have shared their vision for a new, independent Board of Cardiovascular Medicine.

Risk of heart disease skyrockets when young, middle-aged women regularly drink alcohol

"I wasn’t expecting these results among women in this lower age group, because we usually see increased risk for heart disease among older women," one cardiologist said. "It was definitely surprising.”

American College of Cardiology (ACC)

Success in treating congenital heart disease prompted need for new adult guidelines

TAVR or SAVR? Market competition may be influencing these decisions

American College of Cardiology highlights the cardiovascular risks of various cancer treatments

Women are more likely to have severe aortic stenosis missed on echocardiography results

Cardiologists join chorus of voices urging Trump administration to kill cybersecurity proposal